Cost effectiveness analysis of early zidovudine treatment of HIV infected patients

OBJECTIVE--To compare cost effectiveness of early and later treatment with zidovudine for patients infected with HIV. DESIGN--Markov chain analysis of cost effectiveness based on results of use of health care and efficacy from a trial of zidovudine treatment. SETTING--Seven Veterans Affairs medical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 1993-11, Vol.307 (6915), p.1322-1325
Hauptverfasser:	Oddone, E Z, Cowper, P, Hamilton, J D, Matchar, D B, Hartigan, P, Samsa, G, Simberkoff, M, Feussner, J R
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - economics Acquired Immunodeficiency Syndrome - prevention & control AIDS Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Cost analysis Cost effectiveness analysis Cost efficiency Cost of Illness Cost-Benefit Analysis Double-Blind Method Drug Administration Schedule Drug Costs Drug therapy Experimentation Follow-Up Studies Health Care Costs Health care expenditures HIV HIV infections HIV Infections - drug therapy HIV Infections - economics Human immunodeficiency virus Humans Infections Medical research Medical sciences Pharmacology. Drug treatments Quality of Life United States Value of Life Zidovudine - administration & dosage Zidovudine - adverse effects Zidovudine - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!